{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:55:01Z","timestamp":1787025301471,"version":"build-2736575974"},"reference-count":29,"publisher":"Walter de Gruyter GmbH","issue":"1","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,8,26]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Hashimoto\u2019s thyroiditis (HT) and Graves\u2019 disease (GD) are autoimmune thyroid diseases (AITD) that cause hypothyroidism and hyperthyroidism, respectively. The vitamin D receptor (VDR) and the Fey receptor IIA (Fc\u03b3RIIA), are implicated in the etiology of AITD. This study was conducted to examine the implication of\n                    <jats:italic>VDR<\/jats:italic>\n                    rs7975232 and\n                    <jats:italic>FCGR2A<\/jats:italic>\n                    rs 1801274 variations in the susceptibility and the prognosis of AITD in the Tunisian population. The rs7975232 and rs1801274 (R131H) polymorphisms were analyzed in 162 controls and 162 AITD patients (106 HT and 56 GD) by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) and amplification of refractory mutation system-PCR (ARMS-PCR), respectively. No significant difference was demonstrated for the rs7975232 between patients and controls. However, a significant association was shown between the rs1801274 polymorphism and AITD or HT in the dominant (\n                    <jats:italic>p<\/jats:italic>\n                    = 0.03 or\n                    <jats:italic>p =<\/jats:italic>\n                    0.01), codominant (\n                    <jats:italic>p =<\/jats:italic>\n                    0.019 or\n                    <jats:italic>p =<\/jats:italic>\n                    0.026) and allelic (\n                    <jats:italic>p =<\/jats:italic>\n                    0.011\n                    <jats:italic>or p =<\/jats:italic>\n                    0.012) models. The rs7975232 was associated with the absence or the presence of anti-thyroglobulin antibody, with the age of AITD and GD patients during the first diagnosis (\n                    <jats:italic>p =<\/jats:italic>\n                    0.01 and\n                    <jats:italic>p<\/jats:italic>\n                    = 0.009, respectively) and with a high T4 level at the beginning of HT disease. However, the\n                    <jats:italic>FCGR2A<\/jats:italic>\n                    gene polymorphism was associated with a low T4 level at the beginning of GD disease. In conclusion, this study indicates that only the\n                    <jats:italic>FCGR2A<\/jats:italic>\n                    variation could be related to AITD and HT susceptibility and that\n                    <jats:italic>VDR<\/jats:italic>\n                    and\n                    <jats:italic>FCGR2A<\/jats:italic>\n                    gene variations constitute factors to prognosticate the severity of AITD, HT and GD.\n                  <\/jats:p>","DOI":"10.2478\/bjmg-2020-0011","type":"journal-article","created":{"date-parts":[[2020,8,28]],"date-time":"2020-08-28T10:42:38Z","timestamp":1598611358000},"page":"69-76","source":"Crossref","is-referenced-by-count":5,"title":["Implication of\n                    <i>VDR<\/i>\n                    rs7975232 and\n                    <i>FCGR2A<\/i>\n                    rs1801274 gene polymorphisms in the risk and the prognosis of \nautoimmune thyroid diseases in the Tunisian population"],"prefix":"10.2478","volume":"23","author":[{"given":"S","family":"Mestiri","sequence":"first","affiliation":[{"name":"Laboratory of Genetics, Biodiversity and Bioresource Valorization, Superior Institute of Biotechnology of Monastir, University of Monastir , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Zaaber","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics, Biodiversity and Bioresource Valorization, Superior Institute of Biotechnology of Monastir, University of Monastir , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Nasr","sequence":"additional","affiliation":[{"name":"Laboratory of Genetics, Biodiversity and Bioresource Valorization, Superior Institute of Biotechnology of Monastir, University of Monastir , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Marmouch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine-Endocrinology, Hospital Fattouma Bourguiba , Monastir , Tunisia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2020,8,26]]},"reference":[{"key":"2026042718400850448_j_bjmg-2020-0011_ref_001_w2aab3b7b3b1b6b1ab2b2b1Aa","doi-asserted-by":"crossref","unstructured":"Invemizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun. 2009; 33(1): 12-16.","DOI":"10.1016\/j.jaut.2009.03.005"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_002_w2aab3b7b3b1b6b1ab2b2b2Aa","doi-asserted-by":"crossref","unstructured":"Weetman AP. Determinants of autoimmune thyroid disease. Nat Immunol. 2001; 2(9): 769-770.","DOI":"10.1038\/ni0901-769"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_003_w2aab3b7b3b1b6b1ab2b2b3Aa","doi-asserted-by":"crossref","unstructured":"Ramos-Levi AM, Marazuela M. Pathogenesis of thyroid autoimmune disease: The role of cellular mechanisms. Endocrinol Nutr. 2016; 63(8): 421-429.","DOI":"10.1016\/j.endonu.2016.04.003"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_004_w2aab3b7b3b1b6b1ab2b2b4Aa","doi-asserted-by":"crossref","unstructured":"Salmaso C, Bagnasco M, Pesce G, Montagna P, Brizzolara R, Altrinetti V, et al. Regulation of apoptosis in endocrine autoimmunity: Insights from Hashimoto\u2019s thy-roiditis and Graves\u2019 disease. Ann NY Acad Sci. 2002; 966(1): 496-501.","DOI":"10.1111\/j.1749-6632.2002.tb04253.x"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_005_w2aab3b7b3b1b6b1ab2b2b5Aa","doi-asserted-by":"crossref","unstructured":"Giovinazzo S, Vicchio TM, Certo R, Alibrandi A, Palmieri O, Campenn\u00ec A, et al. Vitamin D receptor gene polymorphisms\/haplotypes and serum 25(OH) D3 levels in Hashimoto\u2019s thyroiditis. Endocrine. 2017; 55(2): 599-606.","DOI":"10.1007\/s12020-016-0942-5"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_006_w2aab3b7b3b1b6b1ab2b2b6Aa","doi-asserted-by":"crossref","unstructured":"Bikle DD. Vitamin D, metabolism, mechanism of action, and clinical applications. Chem Biol. 2014; 21(3): 319-329.","DOI":"10.1016\/j.chembiol.2013.12.016"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_007_w2aab3b7b3b1b6b1ab2b2b7Aa","doi-asserted-by":"crossref","unstructured":"Rosen Y, Daich J, Soliman I, Brathwaite E, Shoenfeld Y. Vitamin D and autoimmunity. Scand J Rheumatol. 2016; 45(6): 439-447.","DOI":"10.3109\/03009742.2016.1151072"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_008_w2aab3b7b3b1b6b1ab2b2b8Aa","doi-asserted-by":"crossref","unstructured":"Altieri B, Muscogiuri G, Barrea L, Mathieu C, Vallone CV, Mascitelli L, et al. Does vitamin D play a role in autoimmune endocrine disorders? A proof of concept. Rev Endocr Metab Disord. 2017; 18(3): 335-346.","DOI":"10.1007\/s11154-016-9405-9"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_009_w2aab3b7b3b1b6b1ab2b2b9Aa","doi-asserted-by":"crossref","unstructured":"Meng S, He ST, Jiang WJ, Xiao L, Li DF, Xu J, et al. Genetic susceptibility to autoimmune thyroid diseases in a Chinese Han population: Role of vitamin D receptor gene polymorphisms. Ann Endocrinol. 2015; 76(6): 684-689.","DOI":"10.1016\/j.ando.2015.01.003"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_010_w2aab3b7b3b1b6b1ab2b2c10Aa","doi-asserted-by":"crossref","unstructured":"Gao XR, Yu YG. Meta-analysis of the association between vitamin D receptor polymorphisms and the risk of autoimmune thyroid disease. Int J Endocrinol. 2018; 2018: 2846943. doi: 10.1155\/2018\/2846943. eCollection.","DOI":"10.1155\/2018\/2846943"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_011_w2aab3b7b3b1b6b1ab2b2c11Aa","doi-asserted-by":"crossref","unstructured":"Uitterlinden AG, Fang Y, Van Meurs JB, Pols HA, Van Leeuwen JP. Genetics and biology of vitamin D receptor polymorphisms. Gene. 2004; 338(2): 143-156.","DOI":"10.1016\/j.gene.2004.05.014"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_012_w2aab3b7b3b1b6b1ab2b2c12Aa","doi-asserted-by":"crossref","unstructured":"Ravetch JV, Bolland S. IgG Fc receptors. Annu Rev Immunol. 2001; 19: 275-290.","DOI":"10.1146\/annurev.immunol.19.1.275"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_013_w2aab3b7b3b1b6b1ab2b2c13Aa","doi-asserted-by":"crossref","unstructured":"Takai T. Fc Receptors and Their Role in Immune Regulation and Autoimmunity. J Clin Immunol. 2005; 25(1): 1-18.","DOI":"10.1007\/s10875-005-0353-8"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_014_w2aab3b7b3b1b6b1ab2b2c14Aa","doi-asserted-by":"crossref","unstructured":"Estienne V, Duthoit C, Reichert M, Praetor A, Carayon P, Hunziker W, et al. Androgen-dependent expression of FcgammaRIIB2 by thyrocytes from patients with autoimmune Graves\u2019 disease: a possible molecular clue for sex dependence of autoimmune disease. FASEB J. 2002; 16(9): 1087-1092.","DOI":"10.1096\/fj.01-0998hyp"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_015_w2aab3b7b3b1b6b1ab2b2c15Aa","doi-asserted-by":"crossref","unstructured":"Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, et al. Specificity and affinity of human Fc\u03b3 receptors and their polymorphic variants for human IgG subclasses. Blood. 2009; 113(16): 3716-3725.","DOI":"10.1182\/blood-2008-09-179754"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_016_w2aab3b7b3b1b6b1ab2b2c16Aa","doi-asserted-by":"crossref","unstructured":"Olerup O, Zetterquist H. HLA-DR typing by PCR amplification with sequence specific primers (PCR-SSP) in 2 hours: An alternative to serological DR typing in clinical practice including donor-recipient matching in cadaveric transplantation. Tissue Antigens. 1992; 39(5): 225-235.","DOI":"10.1111\/j.1399-0039.1992.tb01940.x"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_017_w2aab3b7b3b1b6b1ab2b2c17Aa","doi-asserted-by":"crossref","unstructured":"Boumazos S, Grinfeld J, Alexander KM, Murchison JT, Wallace WA, McFarlane P, et al. Association of FcyRIIa R131H polymorphism with idiopathic pulmonary fibrosis severity and progression. BMC Pulm Med. 2010; 10:51.","DOI":"10.1186\/1471-2466-10-51"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_018_w2aab3b7b3b1b6b1ab2b2c18Aa","doi-asserted-by":"crossref","unstructured":"Collins JE, Heward JM, Nithiyananthan R, Nejentsev S, Todd JA, Franklyn JA, et al. Lack of association of the vitamin D receptor gene with Graves\u2019 disease in UK Caucasians. Clin Endocrinol. 2004; 60(5): 618-624.","DOI":"10.1111\/j.1365-2265.2004.02015.x"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_019_w2aab3b7b3b1b6b1ab2b2c19Aa","doi-asserted-by":"crossref","unstructured":"Zarrin R, Bagheri M, Mehdizadeh A, Ayremlou P, Faghfouri AH. The association of FokI and Apal polymorphisms in vitamin D receptor gene with autoimmune thyroid diseases in the northwest of Iran. Med J Islam Repub Iran. 2018; 32:4. doi: 10.14196\/mjiri.32.4. eCollection 2018.","DOI":"10.14196\/mjiri.32.4"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_020_w2aab3b7b3b1b6b1ab2b2c20Aa","doi-asserted-by":"crossref","unstructured":"Simmonds MJ. GWAS in autoimmune thyroid disease: redefining our understanding of pathogenesis. Nat Rev Endocrinol. 2013; 9(5): 277-287.","DOI":"10.1038\/nrendo.2013.56"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_021_w2aab3b7b3b1b6b1ab2b2c21Aa","doi-asserted-by":"crossref","unstructured":"Maciej ewski A, Kowalczyk MJ, Herman W, Czyzyk A, Kowalska M, \u017baba R, et al. Vitamin D receptor gene polymorphisms and autoimmune thyroiditis: Are they associated with disease occurrence and its features? Biomed Res Int. 2019; 2019:8197580. doi: 10.1155\/2019\/8197580. eCollection 2019.","DOI":"10.1155\/2019\/8197580"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_022_w2aab3b7b3b1b6b1ab2b2c22Aa","doi-asserted-by":"crossref","unstructured":"Horst-Sikorska W, Ignaszak-Szczepaniak M, Marcinkowska M, Kaczmarek M, Stajgis M, Slomski R. Association analysis of vitamin D receptor gene polymorphisms with bone mineral density in young women with Graves\u2019 disease. Acta Biochim Pol. 2008; 55(2): 371-380.","DOI":"10.18388\/abp.2008_3085"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_023_w2aab3b7b3b1b6b1ab2b2c23Aa","doi-asserted-by":"crossref","unstructured":"Pani MA, Knapp M, Donner H, Braun J, Baur MP, Usadel KH, et al. Vitamin D receptor allele combinations influence genetic susceptibility to type 1 diabetes in Germans. Diabetes. 2000; 49(3): 504-507.","DOI":"10.2337\/diabetes.49.3.504"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_024_w2aab3b7b3b1b6b1ab2b2c24Aa","doi-asserted-by":"crossref","unstructured":"Whitfield GK, Remus LS, Jurutka PW, Zitzer H, Oza AK, Dang HT, et al. Functionally relevant polymorphisms in the human nuclear vitamin D receptor gene. Mol Cell Endocrinol. 2001; 177(1-2): 145-159.","DOI":"10.1016\/S0303-7207(01)00406-3"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_025_w2aab3b7b3b1b6b1ab2b2c25Aa","doi-asserted-by":"crossref","unstructured":"Boumazos S, Hart SP, Chamberlain LH, Glennie MJ, Dransfield I. Association of Fc\u03b3RIIa (CD32a) with lipid rafts regulates ligand binding activity. J Immunol. 2009; 182(12): 8026-8036.","DOI":"10.4049\/jimmunol.0900107"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_026_w2aab3b7b3b1b6b1ab2b2c26Aa","doi-asserted-by":"crossref","unstructured":"Miko\u015b H, Miko\u015b M, Obara-Moszynsk M, Niedziela M. The role of the immune system and cytokines involved in the pathogenesis of autoimmune thyroid disease (AITD). Endokrynol Pol. 2014; 65(2): 150-155.","DOI":"10.5603\/EP.2014.0021"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_027_w2aab3b7b3b1b6b1ab2b2c27Aa","doi-asserted-by":"crossref","unstructured":"Stein T, Wollschlegel A, Te H, Weiss J, Joshi K, Kinzel B, et al. Interferon regulatory factor 5 and nuclear factor k-B exhibit cooperating but also divergent roles in the regulation of pro-inflammatory cytokines important for the development of TH1 and TH17 responses. FEBS J. 2018; 285(16): 3097-3113.","DOI":"10.1111\/febs.14600"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_028_w2aab3b7b3b1b6b1ab2b2c28Aa","doi-asserted-by":"crossref","unstructured":"Yesmin K, Hargreaves C, Newby PR, Brand OJ, Heward JM, Franklyn JA, et al. Association of Fc\u03b3RIIa with Graves\u2019 disease: A potential role for dysregulated autoantibody clearance in disease onset\/ progression. Clin Endocrinol (Oxf). 2010; 73(1): 119-125.","DOI":"10.1111\/j.1365-2265.2010.03780.x"},{"key":"2026042718400850448_j_bjmg-2020-0011_ref_029_w2aab3b7b3b1b6b1ab2b2c29Aa","doi-asserted-by":"crossref","unstructured":"Choi YM, Kwak MK, Hong SM, Hong EG. Changes in thyroid peroxidase and thyroglobulin antibodies might be associated with Graves\u2019 disease relapse after antithyroid drug therapy. Endocrinol Metab (Seoul). 2019; 34(3): 268-274.","DOI":"10.3803\/EnM.2019.34.3.268"}],"container-title":["Balkan Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/content.sciendo.com\/view\/journals\/bjmg\/23\/1\/article-p69.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/bjmg-2020-0011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:08:39Z","timestamp":1777327719000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/bjmg-2020-0011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,8,26]]},"published-print":{"date-parts":[[2020,8,26]]}},"alternative-id":["10.2478\/bjmg-2020-0011"],"URL":"https:\/\/doi.org\/10.2478\/bjmg-2020-0011","relation":{},"ISSN":["1311-0160"],"issn-type":[{"value":"1311-0160","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,1]]}}}